Andretti Acquisition Corp. II Files S-1

Ticker: POLEW · Form: S-1 · Filed: Jun 28, 2024 · CIK: 2025341

Sentiment: neutral

Topics: spac, registration-statement, sec-filing

TL;DR

Andretti Acquisition Corp. II just filed an S-1, get ready for some potential action.

AI Summary

Andretti Acquisition Corp. II filed an S-1 registration statement on June 28, 2024, for an unspecified amount of securities. The company, incorporated in the Cayman Islands, has its principal executive offices at 7615 Zionsville Road, Indianapolis, Indiana. William M. Brown serves as the Chief Executive Officer.

Why It Matters

This S-1 filing indicates that Andretti Acquisition Corp. II is preparing to offer securities to the public, which could lead to a future IPO or other capital-raising event.

Risk Assessment

Risk Level: medium — As a Special Purpose Acquisition Company (SPAC), the risk is tied to its ability to find and merge with a suitable target company within its timeframe.

Key Players & Entities

FAQ

What is the purpose of this S-1 filing for Andretti Acquisition Corp. II?

The S-1 filing is a registration statement required by the SEC before a company can offer securities to the public, indicating preparations for a potential offering or merger.

When was this S-1 filing submitted?

The S-1 filing was submitted to the SEC on June 28, 2024.

Who is the CEO of Andretti Acquisition Corp. II?

William M. Brown is listed as the Chief Executive Officer of Andretti Acquisition Corp. II.

Where are the principal executive offices of Andretti Acquisition Corp. II located?

The principal executive offices are located at 7615 Zionsville Road, Indianapolis, Indiana 46268.

In which jurisdiction was Andretti Acquisition Corp. II incorporated?

Andretti Acquisition Corp. II was incorporated in the Cayman Islands.

Filing Stats: 3,996 words · 16 min read · ~13 pages · Grade level 19.3 · Accepted 2024-06-28 09:06:53

Key Financial Figures

Filing Documents

Risk Factors

Risk Factors   42 Cautionary Note Regarding Forward-Looking Statements   89

Use of Proceeds

Use of Proceeds   90 Dividend Policy   93

Dilution

Dilution   94 Capitalization   96 Management’s Discussion and Analysis of Financial Condition and Results of Operations   97 Proposed Business   102 Effecting our Initial Business Combination   112 Management   133 Principal Shareholders   145 Certain Relationships and Related Party Transactions   150

Description of Securities

Description of Securities   153 Taxation   174

Underwriting

Underwriting   185 Legal Matters   195 Experts   195 Where You Can Find Additional Information   195 Index to Financial Statements   F-1 We are responsible for the information contained in this prospectus. We have not, and the underwriters have not, authorized anyone to provide you with information that is different from or inconsistent with that contained in this prospectus. We are not, and the underwriters are not, making an offer to sell securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front of this prospectus. Trademarks This prospectus contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies’ trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. i Table of Contents SUMMARY This summary only highlights the more detailed information appearing elsewhere in this prospectus. As this is a summary, it does not contain all of the information that you should consider in making an investment decision. You should read this entire prospectus carefully, including the information under “Risk Factors” and our financial statements and the related notes included elsewhere in this prospectus, before investing. Unless otherwise stated in this prospectus or the context otherwise requires, references to: •      &#x00a

View Full Filing

View this S-1 filing on SEC EDGAR

View on Read The Filing